BPC-157 + GHK-Cu: concentration comparison
Research reference only. Source-reported examples and schedules are not dosing recommendations from MGMT Research. They do not establish safety or suitability. Prescribed medication decisions belong with a licensed clinician and the current product label.
— mL · U-100
Syringe markings measure volume. They are not IU of the compound. Calculations do not account for handling losses or product stability.
— mL · U-100
Syringe markings measure volume. They are not IU of the compound. Calculations do not account for handling losses or product stability.
Reference notes
These two vial labels can describe very different amounts. Work from each vial independently; an identical syringe mark does not establish an identical mass.
The source lists BPC-157 vials of 5–10 mg and GHK-Cu vials of 50–100 mg. It discusses 3–10 mL diluent for GHK-Cu, while its table uses 5 mL. Topical percentage formulations are outside this vial calculation.
| Compound | Vial | Diluent | Target | Units (mL) |
|---|---|---|---|---|
| BPC-157 | 5 mg | 2 mL | 250 mcg | 10 (0.1) |
| BPC-157 | 10 mg | 2 mL | 250 mcg | 5 (0.05) |
| GHK-Cu | 50 mg | 5 mL | 1 mg | 10 (0.1) |
| GHK-Cu | 100 mg | 5 mL | 1 mg | 5 (0.05) |
Source & content review 1 notes
This is an original, concise draft. Full information and numerical parity with the source is not yet established.
Open source reference ↗- Source numeric coverage is partial: selected reference values are preserved; all additional source tables and examples still require reconciliation before claiming full fidelity.
Captured source values
{
"numericalFacts": []
}